Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 10 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 10 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides a source of calories and hydration. It is metabolized to carbon dioxide and water, yielding energy. Sodium chloride provides electrolytes to maintain osmotic balance and fluid distribution.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; dose depends on fluid and caloric needs, typically 100-200 mL/hour for maintenance in adults. Maximum infusion rate: 0.5 g/kg/hour dextrose.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateDextrose has a plasma half-life of approximately 1.5-2 hours under euglycemic conditions, prolonged in renal impairment (not directly applicable as it is continuously infused). Sodium and chloride have no defined half-life; they are handled by renal homeostatic mechanisms with kinetic parameters dependent on GFR and tubular function.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose is completely metabolized to carbon dioxide and water; no significant renal excretion. Sodium and chloride are primarily excreted renally (99% of filtered load reabsorbed, with excess excreted in urine). Fecal/biliary elimination is negligible.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."